Special Focus: Global Health

Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?

While the world lives under the shadow of the novel coronavirus (COVID-19) pandemic, dermatologists wonder if the current situation calls for a temporary change in the management of skin conditions.

GW Announces Virtual Learning Opportunity

| Derm Community, Education, Global Health | No Comments
DC Academy of Dermatology   Monday, March 23, 2020 - 8:30am Register Contact: Kayleigh Hausmann The George Washington University School of Medical and Health Sciences has announced it will host…

Medical Bioethics in Dermatologic Procedures

The US Food and Drug Administration (FDA) held a hearing on the safety of dermal fillers in November of 2008 which generated a great deal of media attention and, more importantly, got our attention. The adverse reporting data came from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database and numbered 930 cases over the past 6 years, bringing the complication rate to an estimated 1 in 10 000. Some of the complications were severe, such as facial palsy or anaphylaxis; while others included scarring. Such rare but grave complications are generally considered acceptable risks for treatments of medical illnesses (eg, infections or carcinomas); but are these rare complications for elective cosmetic enhancement acceptable?

March 18, 2020 in Derm Community, Education, Global Health

GW Announces Virtual Learning Opportunity

DC Academy of Dermatology   Monday, March 23, 2020 - 8:30am Register Contact: Kayleigh Hausmann The George Washington University School of Medical and Health Sciences has announced it will host…
Read More

Sponsored

JDD Highlights

JDD Highlights
March 30, 2020

Current Issue Highlights

New Dermatological Research is available now- view this months' JDD features, case reports, and research below: Dermatologists respond regarding the impact of COVID-19 and examine the potential impact of drugs…

JDD in the Media

JDD in the Media
January 31, 2020

Are Dermatologists Prepared for Natural and Manmade Disasters?

Natural and manmade disasters cause a range of dermatologic manifestations, including secondary infections after a flood, irritation from blistering agents used in chemical warfare, or acute and chronic effects of…

Derm Community

Derm CommunityEducationGlobal Health
March 18, 2020

GW Announces Virtual Learning Opportunity

DC Academy of Dermatology   Monday, March 23, 2020 - 8:30am Register Contact: Kayleigh Hausmann The George Washington University School of Medical and Health Sciences has announced it will host…

Featured Articles

Featured ArticlesGlobal Health
March 30, 2020

Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?

While the world lives under the shadow of the novel coronavirus (COVID-19) pandemic, dermatologists wonder if the current situation calls for a temporary change in the management of skin conditions.…

Podcast Spotlight

Podcast Highlights
March 19, 2020

What Women Don’t Want … Psoriasis

In this edition of the JDD Podcast, Dr. Adam Friedman is joined by Dr. Deirdre Hooper, Associate Clinical Professor in the Department of Dermatology at both Louisiana State University and…

Latest CME Activities

CME Activities
January 29, 2020

Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes

1 CME CreditHuman facial aging is a gradual and ongoing process involving various factors including photodamage, skin laxity, volume loss of subcutaneous tissue, and bony resorption. As the aging US…

Sponsored

Surveys & Giveaways

JDDonline Survey

Tell us what you think: Take the survey below to help us
improve your JDDonline experience.

Get More from the JDD

Subscribe

The Journal of Drugs in Dermatology (JDD) offers complimentary 3-year subscriptions to all US derm HCPs!

Subscribe Today!

Sign Up for Our Newsletter

Stay up to date with the latest hot topics in dermatology: sign up for the eJDD newsletter. Discover the latest research from leading experts in dermatology, find new Podcast episodes, learn about free CME activities, enter our contests and giveaways, and more!

Sign Up!

About the JDD

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

Learn More